» Articles » PMID: 21478876

Amelioration of Sepsis by Inhibiting Sialidase-mediated Disruption of the CD24-SiglecG Interaction

Abstract

Suppression of inflammation is critical for effective therapy of many infectious diseases. However, the high rates of mortality caused by sepsis attest to the need to better understand the basis of the inflammatory sequelae of sepsis and to develop new options for its treatment. In mice, inflammatory responses to host danger-associated molecular patterns (DAMPs), but not to microbial pathogen-associated molecular patterns (PAMPs), are repressed by the interaction [corrected] of CD24 and SiglecG (SIGLEC10 in human). Here we use an intestinal perforation model of sepsis to show that microbial sialidases target the sialic acid-based recognition of CD24 by SiglecG/10 to exacerbate inflammation. Sialidase inhibitors protect mice against sepsis by a mechanism involving both CD24 and Siglecg, whereas mutation of either gene exacerbates sepsis. Analysis of sialidase-deficient bacterial mutants confirms the key contribution of disrupting sialic acid-based pattern recognition to microbial virulence and supports the clinical potential of sialidase inhibition for dampening inflammation caused by infection.

Citing Articles

ST8SIA6 Sialylates CD24 to Enhance Its Membrane Localization in BRCA.

He J, Zhang F, Wu B, Yu W Cells. 2025; 14(1.

PMID: 39791710 PMC: 11719756. DOI: 10.3390/cells14010009.


STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer.

Wang J, Zhang H, Zhu G, Zhao L, Shi J, Dai Z Acta Pharmacol Sin. 2024; .

PMID: 39668180 DOI: 10.1038/s41401-024-01419-0.


Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosis.

Song D, Li Z, Sun F, Wu K, Zhang K, Liu W Stem Cell Res Ther. 2024; 15(1):344.

PMID: 39380037 PMC: 11462801. DOI: 10.1186/s13287-024-03945-4.


Biological function of sialic acid and sialylation in human health and disease.

Zhu W, Zhou Y, Guo L, Feng S Cell Death Discov. 2024; 10(1):415.

PMID: 39349440 PMC: 11442784. DOI: 10.1038/s41420-024-02180-3.


From mechanism to therapy: the journey of CD24 in cancer.

Zhao K, Wu C, Li X, Niu M, Wu D, Cui X Front Immunol. 2024; 15:1401528.

PMID: 38881902 PMC: 11176514. DOI: 10.3389/fimmu.2024.1401528.


References
1.
Dombrovskiy V, Martin A, Sunderram J, Paz H . Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007; 35(5):1244-50. DOI: 10.1097/01.CCM.0000261890.41311.E9. View

2.
Blixt O, Collins B, van den Nieuwenhof I, Crocker P, Paulson J . Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J Biol Chem. 2003; 278(33):31007-19. DOI: 10.1074/jbc.M304331200. View

3.
Yu H, Huang S, Chokhawala H, Sun M, Zheng H, Chen X . Highly efficient chemoenzymatic synthesis of naturally occurring and non-natural alpha-2,6-linked sialosides: a P. damsela alpha-2,6-sialyltransferase with extremely flexible donor-substrate specificity. Angew Chem Int Ed Engl. 2006; 45(24):3938-44. PMC: 2728590. DOI: 10.1002/anie.200600572. View

4.
Liu Y, Chen G, Zheng P . CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Trends Immunol. 2009; 30(12):557-61. PMC: 2788100. DOI: 10.1016/j.it.2009.09.006. View

5.
Hoffmann A, Kerr S, Jellusova J, Zhang J, Weisel F, Wellmann U . Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol. 2007; 8(7):695-704. DOI: 10.1038/ni1480. View